Abstract
The recent creation of several mouse models of mitochondrial diseases has provided new insights into the understanding of human mitochondrial disorders. Whether these animals have clinical or histologic ophthalmologic abnormalities is of great interest given the high frequency of such abnormalities in humans with mitochondrial disorders. In this article, we describe the currently available mouse models for mitochondrial diseases with special emphasis on their ocular phenotype. These mouse models demonstrate multiple and varied ophthalmologic manifestations.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Animals
-
Chimera
-
Chloramphenicol / pharmacology
-
DNA-Binding Proteins*
-
Disease Models, Animal
-
Drug Resistance / genetics
-
Eye Diseases / genetics*
-
High Mobility Group Proteins
-
Mice
-
Mice, Knockout
-
Mitochondrial Diseases / genetics*
-
Mitochondrial Proteins*
-
Mutation
-
Nuclear Proteins / deficiency
-
Nuclear Proteins / genetics
-
Protein Synthesis Inhibitors / pharmacology
-
Repressor Proteins / genetics
-
Superoxide Dismutase / genetics
-
Transcription Factors / deficiency
-
Transcription Factors / genetics
-
Viral Proteins / genetics
Substances
-
Ant protein, Enterobacteria phage P22
-
DNA-Binding Proteins
-
High Mobility Group Proteins
-
Mitochondrial Proteins
-
Nuclear Proteins
-
Protein Synthesis Inhibitors
-
Repressor Proteins
-
Tfam protein, mouse
-
Transcription Factors
-
Viral Proteins
-
mitochondrial transcription factor A
-
Chloramphenicol
-
Superoxide Dismutase
-
superoxide dismutase 2